Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will be participating in the following investor conferences:

• Cowen 41^st Annual Health Care Conference
  Date: Monday, March 1^st at 2:40 p.m. Eastern Time

• H.C. Wainwright Global Life Sciences Conference
  Date: Tuesday, March 9^th at 7:00 a.m. Eastern Time

• Barclays Global Healthcare Conference
  Date: Wednesday, March 10^th at 10:55 a.m. Eastern Time

For presentations that are webcast live, an access link will be available on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.